Susquehanna International Group’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$51K 12914
2022
Q4
$51K Hold
1
﹤0.01% 11390
2022
Q3
$63K Sell
1
-2
-67% -$140K ﹤0.01% 12059
2022
Q2
$182K Sell
3
-2
-40% -$141K ﹤0.01% 10768
2022
Q1
$507K Buy
+5
New +$488K ﹤0.01% 8932
2021
Q3
Sell
-1
Closed -$98K 13022
2021
Q2
$98K Hold
1
﹤0.01% 12102
2021
Q1
$189K Sell
1
-4
-80% -$879K ﹤0.01% 11466
2020
Q4
$998K Buy
5
+3
+150% +$464K ﹤0.01% 6732
2020
Q3
$308K Buy
+2
New +$315K ﹤0.01% 8651
2020
Q2
Sell
-1
Closed -$110K 10398
2020
Q1
$110K Buy
+1
New +$103K ﹤0.01% 9254

Other funds holding GNPX

Susquehanna International Group's GNPX Position: Q4 2025 in Review

Susquehanna International Group sold out of Genprex (GNPX) in Q4 2025, closing a stake of 309 shares — an estimated $57.6K sold.

Susquehanna International Group first reported a position in GNPX in Q1 2020 and held it in 12 quarters. The position peaked at $1.42M in Q1 2021. 9 funds tracked by Wall St. Rank hold GNPX as of Q4 2025.

  • Susquehanna International Group reported no remaining Genprex position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 309 Genprex shares in Q4 2025, an estimated $57.6K.
  • Susquehanna International Group first reported a position in Genprex in Q1 2020 and held it in 12 quarters.
  • Susquehanna International Group's Genprex position peaked at $1.42M in Q1 2021.
  • 9 funds tracked by Wall St. Rank held Genprex as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.